1Fern 6ndez-Torres R, Verea MM, Alvarez A, et al. Systemic mastocytosis associated with splenic marginal zone lymphoma with vious lymphocytes[J]. Dermatol Res Pract, 2011:385074.
2Pardanani A. Systemic mastocytosis in adults: 2011 update on diagnosis, risk stratification, and management[J].Am J Hematol, 2011, 86(4): 362-371.
5Pardanani A, Tefferi A. Systemic mastocytosis in adults: a review on prognosis and treatment based on 342 Mayo Clinic patients andcurrent literature. Curt Opin Hematol, 2010,17 : 125-132.
6Ellis JM. Urticaria pigmentosa, a report of a case with autopsy. Arch Patho ( Chic ) , 1949,48:426-435.
7Akoglu G, Erkin G, Cakir B, et al. Cutaneous mastocytosis: demographic aspects and clinical features of 55 patients. J Eur Acad Dermatol Venereol, 2006,20:969-973.
8Pardanani A. Systemic mastocytosis in adults: 2011 update on diagnosis, risk stratification, and vaalagement. Am J Hematol, 2011, 86: 362-371.
9Akin C. Molecular diagnosis of mast cell disorders: a paper from the 2005 William Beaumont Hospital Symposium on Molecular Pathology. J Mol Diagn, 2006, 8 : 412-419.
10Garcia-Montero AC, Jara-Acevedo M, Teodosio C, et al. KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients. Blood, 2006, 108: 2366-2372.
